Ana Guimarães‐Walker

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8⁺T-Cell Epitopes

Nilu Goonetilleke, S. S. Moore, Len Dally et al. · Journal of Virology · 2006 · 236 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

Pierre‐Alexandre Bart, Ruth Goodall, Tristan Barber et al. · Vaccine · 2008 · 59 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

Ana Guimarães‐Walker, N Mackie, Sean McCormack et al. · Vaccine · 2008 · 56 citations

Life Sciences, Immunology, Infectious Diseases +17

Increased detection of proliferating, polyfunctional, HIV‐1‐specific T cells in DNA‐modified vaccinia virus Ankara‐vaccinated human volunteers by cultured IFN‐γ ELISPOT assay

Nicola Winstone, Ana Guimarães‐Walker, Joanna Roberts et al. · European Journal of Immunology · 2009 · 26 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects

Sarah Howles, Ana Guimarães‐Walker, Hongbing Yang et al. · Vaccine · 2010 · 19 citations

Life Sciences, Immunology, Infectious Diseases +14